Link Pharma Chem Ltd (LINKPH) is currently trading at 25.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Link Pharma Chem Limited is a mid‑size chemical manufacturer and exporter incorporated in 1986, producing multi‑range intermediates for pharmaceutical, agrochemical and specialty chemical industries from its Nandesari, Gujarat facility, specialising in corrosive chemistries such as chlorine, oleum and chlorosulphonic acid while offering contract manufacturing and multi‑step synthesis development services. In FY2026 the company reported total income of Rs.2,763.49 lakhs and revenue from operations of Rs.2,743.15 lakhs, delivering a small net profit of Rs.7.69 lakhs compared with a net loss the prior year, reflecting a year‑on‑year operational turnaround driven by improved operating cash flow and modest cost control. Operating cash flow strengthened to Rs.214.65 lakhs and cash and cash equivalents rose to Rs.54.59 lakhs at year‑end; the company invested Rs.209.99 lakhs in property, plant and equipment during the year, financed by a mix of long‑term borrowings, unsecured loans and working‑capital borrowings, indicating focused reinvestment into manufacturing capabilities. Governance and compliance highlights include an unmodified statutory audit opinion for FY2026, board approvals to reappoint Chairman Satish G. Thakur and Managing Director Rishikesh Thakur, and management’s assessment that India’s consolidated Labour Codes have no material financial impact on the company’s financial statements.

Over the past 52 weeks, Link Pharma Chem Ltd has traded between a low of ₹21.00 and a high of ₹34.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Link Pharma Chem Ltd has a market capitalization of approximately 11.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Link Pharma Chem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -47.17 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 11.32 Cr, Link Pharma Chem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Link Pharma Chem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Link Pharma Chem Ltd is -47.17. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.